Crédit Industriel et Commercial’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-53,600
Closed -$398K 387
2026
Q1
$398K Buy
+53,600
New +$349K 0.03% 261

Crédit Industriel et Commercial's KZR Position: Q2 2026 in Review

Crédit Industriel et Commercial sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 53,600 shares — an estimated $398K sold.

Crédit Industriel et Commercial first reported a position in KZR in Q1 2026 and held it in 1 quarter. The position peaked at $398K in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

  • Crédit Industriel et Commercial reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Crédit Industriel et Commercial sold 53,600 Kezar Life Sciences shares in Q2 2026, an estimated $398K.
  • Crédit Industriel et Commercial first reported a position in Kezar Life Sciences in Q1 2026 and held it in 1 quarter.
  • Crédit Industriel et Commercial's Kezar Life Sciences position peaked at $398K in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.